Table 6 GNP doses administered per animal
From: A novel nasal powder formulation of glucagon: toxicology studies in animal models
Animal | Target (mg) | Actual (mg) | % of target |
|---|---|---|---|
2001B | 0.5 | 0.39 | 78 |
2002B | 0.5 | 0.70 | 140 |
2103B | 0.5 | 0.49 | 98 |
2004B | 0.5 | 0.29 | 58 |
2105B | 0.5 | 0.63 | 126 |
2006D | 0.5 | 0.74 | 148 |
2007D | 0.5 | 0.24 | 48 |
2008D | 0.5 | 0.32 | 64 |
Mean | 0.5 | 0.48 | 95.0 |
2501B | 0.5 | 0.55 | 110 |
2502B | 0.5 | 0.56 | 112 |
2603B | 0.5 | 0.61 | 122 |
2504B | 0.5 | 0.60 | 120 |
2505B | 0.5 | 0.47 | 94 |
2506D | 0.5 | 0.50 | 100 |
2507D | 0.5 | 0.64 | 128 |
2608D | 0.5 | 0.14 | 28 |
Mean | 0.5 | 0.51 | 101.8 |